Quadria Capital, a Singapore-based private equity company, has successfully closed its Fund III fundraising round, aimed at revolutionizing healthcare across Asia. The fundraising effort exceeded expectations by securing a total of $1.07 billion in commitments, surpassing its initial target of $800 million. This round is 60% larger than Quadria Capital’s previous fund, which raised $600 million in 2020.
The oversubscribed Fund III consists of over $954 million in primary commitments and an additional $114 million in committed co-investment capital. Once fully allocated, the total capital pledged is expected to reach approximately $1.3 billion, with a potential further $300 million in co-investment opportunities during the investment period.
Abrar Mir, co-founder and managing partner of Quadria Capital, expressed his satisfaction with the successful close of Fund III amidst a challenging fundraising environment. He stated, “Fund III’s close, amid one of the most demanding fundraising climates in recent memory, is a powerful validation of our strategy and our mission. It reflects deep global investor conviction in the transformational opportunity in Asian Healthcare, where social impact and financial performance go hand in hand.”
Quadria Capital received strong support from its existing major backers, including North American and European sovereign wealth funds, strategic corporates, and asset managers. Institutional backers and investors from the Gulf Cooperation Council (GCC) nations, such as Saudi Arabia, the United Arab Emirates, and Bahrain, also pledged their support. Indian investors, including banks, insurance companies, and family offices, have shown interest and contributed capital to the fund.
The successful fundraising round positions Quadria Capital for structural growth in Vietnam, where the healthcare market is valued at $25 billion. The company’s investment in FV Hospital, one of Vietnam’s largest healthcare providers, has already led to significant clinical improvements and enhanced patient outcomes.
Last year, Quadria Capital was in advanced discussions to acquire a minority stake in NephroPlus, an India-based dialysis chain, for approximately Rs20 billion ($250 million).
This article, “Quadria Capital closes Fund III fundraising round to advance healthcare at $1.07 billion,” was originally published by Hospital Management, a GlobalData-owned brand.
Please note that the information provided in this article is for general informational purposes only and should not be considered as professional advice. It is recommended to seek professional or specialist advice before making any decisions based on the content of this article.
